Jump to content
Powered by

Diagnostics

The latest articles, press releases and dossiers on diagnostics in Baden-Württemberg

  • Article - 25/02/2013

    Premature births are not uncommon in Germany where around seven percent of newborns are born before week 37 of pregnancy. The WHO estimates that the numbers of preterm births are growing due to the increasing age of mothers. Doctors caring for the tiny patients are faced with a dilemma because regular blood samples required for the clinical monitoring of important blood parameters cannot be taken due to the infants’ low body volume.

  • Article - 04/02/2013

    The Department of Cardiology at Heidelberg University Hospital and Siemens Corporate Technology have been working together since 2011 to develop new software that improves the diagnosis of heart diseases. The new software analyses and manages data related to the genetic causes of cardiomyopathy and presents the data to physicians in a clear manner. Specific microRNAs in the blood of patients have the potential of being used as new biomarkers,…

  • Article - 04/02/2013

    “capmatch medical” was specifically designed for young medical device and biotech companies that are seeking capital from investors in Europe. Combined with professional coaching and process management, capmatch medical’s matching approach improves the chances of successful matchmaking between companies and dedicated investors.

  • Article - 28/01/2013

    Juvenile myelomonocytic leukaemia (JMML) is the most common chronic cancer of the blood in children and tends to have a poor response to chemotherapy. Prof. Dr. Christian Flotho and his team from the Centre of Paediatric and Adolescent Medicine in Freiburg have shown that epigenetic mechanisms play a key role in the pathogenesis of JMML. As part of a German Research Foundation priority programme, the researchers from Freiburg are working on…

  • Article - 21/01/2013

    The large international project SyStemAge is specifically focused on the role of stem cells in ageing and age-related diseases such as myelodysplastic syndrome and B-cell chronic lymphocytic leukaemia. Coordinated by the European Molecular Biology Laboratory and the Heidelberg University Hospital, the SyStemAge consortium seeks to identify the causes and molecular pathways associated with the processes of ageing on the stem-cell level as well as…

  • Article - 07/01/2013

    Patients with common variable immunodeficiency (CVID) lack antibodies that would protect them against infections. Only a handful of patients develop the disease because of a single defect in any of the genes involved in CVID pathogenesis. A group of researchers led by Dr. Ulrich Salzer at the Centre for Chronic Immunodeficiency (CCI) at the University of Freiburg Medical Centre investigates how small RNA molecules control B-lymphocyte development…

  • Article - 31/12/2012

    Can myocardial infarction be diagnosed with a single drop of blood? The answer is yes: a new application of the ESEQuant Lateral Flow System developed by QIAGEN now makes this possible. The system, which is able to identify a broad range of bacterial and viral pathogens, including HIV, influenza virus and Chlamydia, was originally developed at the company’s site in Stockach. It has recently been adapted for use in the diagnosis of myocardial…

  • Article - 17/12/2012

    Rare diseases are conditions that are too often neglected by research, industry and medicine. Here we use Wilson’s disease as an example to illustrate the particular problems associated with research into and treatment of rare diseases and to provide information on measures that can be taken to improve the situation of people with rare diseases. These measures include central treatment and care institutions and programmes like the Wilson’s…

  • Press release - 26/11/2012

    An estimated 220 million people become infected with malaria each year. The disease is often lethal – particularly in tropical developing countries with insufficient health care services. The infected suffer from a high fever. As this is also the case with other germs, however, it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy. A team of researchers aims to develop a rapid test…

  • Article - 19/11/2012

    The prostate genome project, which is part of the International Cancer Genome Consortium, is focused on the genetic and epigenetic causes of the development and progression of this highly variable cancer and finding markers that enable the reliable diagnosis of the disease. The German research groups involved in the project are coordinated by the German Cancer Research Center and concentrate on prostate cancer patients under 50 years of age, as…

Website address: https://www.gesundheitsindustrie-bw.de/en/article/diagnostics